Skip to main content
. 2018 May 18;315(3):H634–H643. doi: 10.1152/ajpheart.00155.2018

Fig. 1.

Fig. 1.

Body weight (A) and heart weight (B) from control, synthetic humanin analog (HNG) alone-, dexrazoxane (DRZ) alone-, DRZ + HNG-, doxorubicin (Dox) alone-, Dox + HNG-, Dox + DRZ-, and Dox + HNG + DRZ-treated mice.